Canterbury DHB


Diagnostic Criteria for CEL

Diagnostic criteria for CEL (WHO 2016)

*Certain gene mutations (e.g. DNMT3A, TET2, ASXL1 with variant allele frequency ≥ 2%) can be seen in a subpopulation of elderly patients who do not have haematologic disorders, otherwise known as clonal haematopoiesis of indeterminate potential. Therefore, diagnostic interpretation should be done with caution.2,3

About this Canterbury DHB document (537414):

Document Owner:

Bridgett McDiarmid (see Who's Who)

Last Reviewed:

August 2018

Next Review:

April 2021


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 537414